Christopher J Twelves Selected Research

Christopher J Twelves Research Topics

9	Neoplasms (Cancer) 01/2018 - 02/2002
5	Breast Neoplasms (Breast Cancer) 02/2016 - 11/2006
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Infections 01/2018
1	Glioma (Gliomas) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 10/2016
1	Colonic Neoplasms (Colon Cancer) 07/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2007
1	Transitional Cell Carcinoma 10/2006
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2006

4	AnthracyclinesIBA 02/2016 - 11/2006
2	Epirubicin (Ellence)FDA LinkGeneric 02/2016 - 11/2006
2	Fluorouracil (Carac)FDA LinkGeneric 05/2015 - 11/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 11/2006
2	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 11/2006
1	InterferonsIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	IMA950IBA 10/2016
1	Temozolomide (Temodar)FDA LinkGeneric 10/2016
1	HLA-A Antigens (HLA-A)IBA 10/2016
1	VaccinesIBA 10/2016
1	Peptides (Polypeptides)IBA 10/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2016
1	Histones (Histone)IBA 02/2016
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	Zoledronic Acid (Zometa)FDA Link 01/2016
1	TegafurIBA 07/2013
1	Sodium Glutamate (Accent)IBA 07/2013
1	UracilIBA 07/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 07/2013
1	Capecitabine (Xeloda)FDA Link 07/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 04/2013
1	Formaldehyde (Formol)FDA Link 04/2013
1	ParaffinIBA 04/2013
1	DNA (Deoxyribonucleic Acid)IBA 07/2011
1	N- (6,6- dimethyl- 5- ((1- methylpiperidin- 4- yl)carbonyl)- 1,4,5,6- tetrahydropyrrolo(3,4- c)pyrazol- 3- yl)- 3- methylbutanamideIBA 03/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2011
1	Drug CombinationsIBA 01/2007
1	IsoenzymesIBA 01/2007
1	Estrogen ReceptorsIBA 11/2006
1	apaziquone (E 09)IBA 10/2006
1	Pemetrexed (MTA)FDA Link 02/2002

4	Therapeutics 01/2018 - 11/2006
4	Drug Therapy (Chemotherapy) 02/2016 - 07/2011
1	Intravenous Infusions 01/2018
1	Immunotherapy 01/2018
1	Intralesional Injections 01/2018
1	Intravenous Administration 01/2018
1	Chemoradiotherapy 10/2016
1	Adjuvant Chemotherapy 05/2015
1	Intravesical Administration 10/2006